Clinical testing service for safer dosing of warfarin Machaon Diagnostics, California’s only independent laboratory for testing bleeding and clotting disorders has launched a clinical assessment service for patients that have been prescribed warfarin. Machaon’s FDA-approved array-centered technology detects genetic variations in 2 crucial genes mixed up in metabolism of warfarin indian pharmaceutical companies . Related StoriesBerkeley Lab scientists identify genetic elements that influence neurological disorders and body weightTesting amniotic fluid could guidebook doctors to make delivery planning decisions for preterm birthsNew medical trial on breast cancer may help deal with and control diseaseTraditional warfarin dosing is largely based on learning from your errors.
Clinical study to evaluate high-dose vitamin D supplements for MS Doctors in several centers over the U.S. Are recruiting people who have multiple sclerosis to look for the effectiveness of high-dose vitamin D supplements for lowering MS disease activity. The vitamin supplements would be put into regular therapy with glatiramer acetate . The scholarly study, funded by the National Multiple Sclerosis Culture, is being led by Ellen Mowry, MD, MCR, at Johns Hopkins University in Baltimore. Other towns with centers recruiting individuals include Portland, St. Louis, and SAN FRANCISCO BAY AREA, and additional centers are being founded.